Sale!

CTSD Gene Ceroid lipofuscinosis neuronal type 10 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CTSD Gene Ceroid Lipofuscinosis Neuronal Type 10 Genetic Test is a specialized diagnostic tool designed to identify mutations in the CTSD gene, which are associated with Neuronal Ceroid Lipofuscinosis Type 10 (NCL10), a rare and severe neurodegenerative disorder. This condition is part of a group of lysosomal storage diseases known as Batten disease, characterized by the accumulation of lipopigments in the body’s tissues, leading to symptoms such as vision loss, motor decline, and cognitive impairment.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test aims to provide conclusive evidence for the diagnosis of NCL10, enabling healthcare professionals to tailor treatment plans and offer genetic counseling to affected families. The test is particularly valuable for families with a history of the disorder or individuals showing symptoms suggestive of NCL10.

The cost of the CTSD Gene Ceroid Lipofuscinosis Neuronal Type 10 Genetic Test is 4400 AED. While the price may seem steep, the test offers invaluable insights into the genetic underpinnings of the disease, paving the way for targeted interventions and support for patients and their families. It is an essential resource for those seeking clarity on their genetic status regarding this rare but impactful condition.

Description

CTSD Gene Ceroid lipofuscinosis neuronal type 10 Genetic Test

Components: CTSD Gene Ceroid lipofuscinosis neuronal type 10 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CTSD Gene Ceroid lipofuscinosis neuronal type 10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 10.

Test Details: CTSD gene ceroid lipofuscinosis neuronal type 10 (CLN10) is a rare genetic disorder that affects the nervous system. It is caused by mutations in the CTSD gene, which provides instructions for producing an enzyme called cathepsin D. This enzyme is involved in the breakdown and recycling of cellular waste products. Individuals with CLN10 typically experience progressive neurological symptoms, including seizures, movement disorders, cognitive decline, and vision loss. The age of onset and severity of symptoms can vary widely.

NGS genetic testing can be used to identify mutations in the CTSD gene and confirm a diagnosis of CLN10. NGS, or next-generation sequencing, is a high-throughput DNA sequencing technology that can rapidly analyze multiple genes simultaneously. This allows for a more comprehensive and efficient genetic analysis compared to traditional sequencing methods.

Genetic testing for CLN10 can help to confirm a diagnosis, provide information about the specific genetic mutation involved, and offer guidance for managing the condition. It can also be useful for identifying carriers of the mutation in at-risk family members and for prenatal testing in families with a known mutation. It is important to note that genetic testing for CLN10 should be performed by a qualified healthcare professional or genetic counselor, who can provide appropriate counseling and interpretation of the results.

Test Name	CTSD Gene Ceroid lipofuscinosis neuronal type 10 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CTSD Gene Ceroid lipofuscinosis neuronal type 10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 10
Test Details	CTSD gene ceroid lipofuscinosis neuronal type 10 (CLN10) is a rare genetic disorder that affects the nervous system. It is caused by mutations in the CTSD gene, which provides instructions for producing an enzyme called cathepsin D. This enzyme is involved in the breakdown and recycling of cellular waste products. Individuals with CLN10 typically experience progressive neurological symptoms, including seizures, movement disorders, cognitive decline, and vision loss. The age of onset and severity of symptoms can vary widely. NGS genetic testing can be used to identify mutations in the CTSD gene and confirm a diagnosis of CLN10. NGS, or next-generation sequencing, is a high-throughput DNA sequencing technology that can rapidly analyze multiple genes simultaneously. This allows for a more comprehensive and efficient genetic analysis compared to traditional sequencing methods. Genetic testing for CLN10 can help to confirm a diagnosis, provide information about the specific genetic mutation involved, and offer guidance for managing the condition. It can also be useful for identifying carriers of the mutation in at-risk family members and for prenatal testing in families with a known mutation. It is important to note that genetic testing for CLN10 should be performed by a qualified healthcare professional or genetic counselor, who can provide appropriate counseling and interpretation of the results.